Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying

[Display omitted] The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmaceutics and biopharmaceutics 2016-12, Vol.109, p.72-80
Hauptverfasser: Ceschan, Nazareth Eliana, Bucalá, Verónica, Ramírez-Rigo, María Verónica, Smyth, Hugh David Charles
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 80
container_issue
container_start_page 72
container_title European journal of pharmaceutics and biopharmaceutics
container_volume 109
creator Ceschan, Nazareth Eliana
Bucalá, Verónica
Ramírez-Rigo, María Verónica
Smyth, Hugh David Charles
description [Display omitted] The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to focus on dry powder inhaler delivery systems. Atenolol is an antihypertensive drug with low oral bioavailability and gastrointestinal side effects. Because atenolol possesses adequate permeation across human epithelial membranes, it has been proposed as a good candidate for inhalatory administration. In a previous work, atenolol was combined with alginic acid (AA) and microparticles were developed using spray-drying (SD) technology. Different AA/atenolol ratios, total feed solid content and operative variables were previously explored. In order to improve particle quality for inhalatory administration and the SD yield, in this work the AA acid groups not neutralized by atenolol were kept either free or neutralized to pH∼7 and two different SD cyclones were used. Particle morphology, flow properties, moisture uptake and in vitro aerosolization behavior at different pressure drops were studied. When the AA acid groups were neutralized, particle size decreased as a consequence of the lower feed viscosity. The SD yield and in vitro particle deposition significantly increased when a high performance cyclone was employed, and even when lactose carrier particles were not used. Although the in vitro particle deposition decreased when the storage relative humidity increased, the developed SD powders showed adequate characteristics to be administered by inhalatory route up to storage relative humidities of about 60%.
doi_str_mv 10.1016/j.ejpb.2016.09.020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835355149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0939641116306233</els_id><sourcerecordid>1835355149</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-1a8bb6b695693e37b1709e08a35fdf7efa9bd45e90aee7dd70980aba396ae7583</originalsourceid><addsrcrecordid>eNp9UcFu1TAQtBCIPtr-AAfkI5cE-zlOYokLqqBUqsQFztba3hQ_JXawk0r5An4bh9dy5LSr3ZmxZ4eQt5zVnPH2w6nG02zqY-lrpmp2ZC_IgfedqETT8JfkwJRQVdtwfkHe5HxijDWd7F-Ti2PXqk4qeSC_76YZ7ELjQAdER21cw4LJx0DBOb_8bUKZb3aMAemyzUj3GabotgCTt9TgT3j0Me0iMD744G0FC4Y4xpEWQIozpMXbETOdC2215SGz0Twn2KhLmw8PV-TVAGPG66d6SX58-fz95mt1_-327ubTfWWFbJeKQ29Ma1olWyVQdIZ3TCHrQcjBDR0OoIxrJCoGiJ1zZdszMCBUC1i8i0vy_qxbPvJrxbzoyWeL4wgB45o174UUUvJGFejxDC0Gck446Dn5CdKmOdN7APqk9wD0HoBmSpcACundk_5qJnT_KM8XL4CPZwAWl48ek87WYygn8Qntol30_9P_A9MFmr4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835355149</pqid></control><display><type>article</type><title>Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ceschan, Nazareth Eliana ; Bucalá, Verónica ; Ramírez-Rigo, María Verónica ; Smyth, Hugh David Charles</creator><creatorcontrib>Ceschan, Nazareth Eliana ; Bucalá, Verónica ; Ramírez-Rigo, María Verónica ; Smyth, Hugh David Charles</creatorcontrib><description>[Display omitted] The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to focus on dry powder inhaler delivery systems. Atenolol is an antihypertensive drug with low oral bioavailability and gastrointestinal side effects. Because atenolol possesses adequate permeation across human epithelial membranes, it has been proposed as a good candidate for inhalatory administration. In a previous work, atenolol was combined with alginic acid (AA) and microparticles were developed using spray-drying (SD) technology. Different AA/atenolol ratios, total feed solid content and operative variables were previously explored. In order to improve particle quality for inhalatory administration and the SD yield, in this work the AA acid groups not neutralized by atenolol were kept either free or neutralized to pH∼7 and two different SD cyclones were used. Particle morphology, flow properties, moisture uptake and in vitro aerosolization behavior at different pressure drops were studied. When the AA acid groups were neutralized, particle size decreased as a consequence of the lower feed viscosity. The SD yield and in vitro particle deposition significantly increased when a high performance cyclone was employed, and even when lactose carrier particles were not used. Although the in vitro particle deposition decreased when the storage relative humidity increased, the developed SD powders showed adequate characteristics to be administered by inhalatory route up to storage relative humidities of about 60%.</description><identifier>ISSN: 0939-6411</identifier><identifier>EISSN: 1873-3441</identifier><identifier>DOI: 10.1016/j.ejpb.2016.09.020</identifier><identifier>PMID: 27697595</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Administration, Inhalation ; Aerosols ; Alginates - administration &amp; dosage ; Alginates - chemistry ; Animals ; Antihypertensive Agents - chemistry ; Atenolol ; Atenolol - administration &amp; dosage ; Atenolol - chemistry ; Desiccation ; Drug Delivery Systems ; Dry Powder Inhalers ; Freeze Drying ; Glucuronic Acid - administration &amp; dosage ; Glucuronic Acid - chemistry ; Hexuronic Acids - administration &amp; dosage ; Hexuronic Acids - chemistry ; Humans ; Hydrogen-Ion Concentration ; In vitro deposition ; Inhalatory administration ; Ionic interaction ; Lactose - chemistry ; Lung - drug effects ; Microscopy, Electron, Scanning ; Microspheres ; Particle Size ; Powders ; Pressure ; Spray-drying ; Viscosity</subject><ispartof>European journal of pharmaceutics and biopharmaceutics, 2016-12, Vol.109, p.72-80</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-1a8bb6b695693e37b1709e08a35fdf7efa9bd45e90aee7dd70980aba396ae7583</citedby><cites>FETCH-LOGICAL-c356t-1a8bb6b695693e37b1709e08a35fdf7efa9bd45e90aee7dd70980aba396ae7583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0939641116306233$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27697595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ceschan, Nazareth Eliana</creatorcontrib><creatorcontrib>Bucalá, Verónica</creatorcontrib><creatorcontrib>Ramírez-Rigo, María Verónica</creatorcontrib><creatorcontrib>Smyth, Hugh David Charles</creatorcontrib><title>Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying</title><title>European journal of pharmaceutics and biopharmaceutics</title><addtitle>Eur J Pharm Biopharm</addtitle><description>[Display omitted] The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to focus on dry powder inhaler delivery systems. Atenolol is an antihypertensive drug with low oral bioavailability and gastrointestinal side effects. Because atenolol possesses adequate permeation across human epithelial membranes, it has been proposed as a good candidate for inhalatory administration. In a previous work, atenolol was combined with alginic acid (AA) and microparticles were developed using spray-drying (SD) technology. Different AA/atenolol ratios, total feed solid content and operative variables were previously explored. In order to improve particle quality for inhalatory administration and the SD yield, in this work the AA acid groups not neutralized by atenolol were kept either free or neutralized to pH∼7 and two different SD cyclones were used. Particle morphology, flow properties, moisture uptake and in vitro aerosolization behavior at different pressure drops were studied. When the AA acid groups were neutralized, particle size decreased as a consequence of the lower feed viscosity. The SD yield and in vitro particle deposition significantly increased when a high performance cyclone was employed, and even when lactose carrier particles were not used. Although the in vitro particle deposition decreased when the storage relative humidity increased, the developed SD powders showed adequate characteristics to be administered by inhalatory route up to storage relative humidities of about 60%.</description><subject>Administration, Inhalation</subject><subject>Aerosols</subject><subject>Alginates - administration &amp; dosage</subject><subject>Alginates - chemistry</subject><subject>Animals</subject><subject>Antihypertensive Agents - chemistry</subject><subject>Atenolol</subject><subject>Atenolol - administration &amp; dosage</subject><subject>Atenolol - chemistry</subject><subject>Desiccation</subject><subject>Drug Delivery Systems</subject><subject>Dry Powder Inhalers</subject><subject>Freeze Drying</subject><subject>Glucuronic Acid - administration &amp; dosage</subject><subject>Glucuronic Acid - chemistry</subject><subject>Hexuronic Acids - administration &amp; dosage</subject><subject>Hexuronic Acids - chemistry</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>In vitro deposition</subject><subject>Inhalatory administration</subject><subject>Ionic interaction</subject><subject>Lactose - chemistry</subject><subject>Lung - drug effects</subject><subject>Microscopy, Electron, Scanning</subject><subject>Microspheres</subject><subject>Particle Size</subject><subject>Powders</subject><subject>Pressure</subject><subject>Spray-drying</subject><subject>Viscosity</subject><issn>0939-6411</issn><issn>1873-3441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcFu1TAQtBCIPtr-AAfkI5cE-zlOYokLqqBUqsQFztba3hQ_JXawk0r5An4bh9dy5LSr3ZmxZ4eQt5zVnPH2w6nG02zqY-lrpmp2ZC_IgfedqETT8JfkwJRQVdtwfkHe5HxijDWd7F-Ti2PXqk4qeSC_76YZ7ELjQAdER21cw4LJx0DBOb_8bUKZb3aMAemyzUj3GabotgCTt9TgT3j0Me0iMD744G0FC4Y4xpEWQIozpMXbETOdC2215SGz0Twn2KhLmw8PV-TVAGPG66d6SX58-fz95mt1_-327ubTfWWFbJeKQ29Ma1olWyVQdIZ3TCHrQcjBDR0OoIxrJCoGiJ1zZdszMCBUC1i8i0vy_qxbPvJrxbzoyWeL4wgB45o174UUUvJGFejxDC0Gck446Dn5CdKmOdN7APqk9wD0HoBmSpcACundk_5qJnT_KM8XL4CPZwAWl48ek87WYygn8Qntol30_9P_A9MFmr4</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Ceschan, Nazareth Eliana</creator><creator>Bucalá, Verónica</creator><creator>Ramírez-Rigo, María Verónica</creator><creator>Smyth, Hugh David Charles</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201612</creationdate><title>Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying</title><author>Ceschan, Nazareth Eliana ; Bucalá, Verónica ; Ramírez-Rigo, María Verónica ; Smyth, Hugh David Charles</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-1a8bb6b695693e37b1709e08a35fdf7efa9bd45e90aee7dd70980aba396ae7583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Administration, Inhalation</topic><topic>Aerosols</topic><topic>Alginates - administration &amp; dosage</topic><topic>Alginates - chemistry</topic><topic>Animals</topic><topic>Antihypertensive Agents - chemistry</topic><topic>Atenolol</topic><topic>Atenolol - administration &amp; dosage</topic><topic>Atenolol - chemistry</topic><topic>Desiccation</topic><topic>Drug Delivery Systems</topic><topic>Dry Powder Inhalers</topic><topic>Freeze Drying</topic><topic>Glucuronic Acid - administration &amp; dosage</topic><topic>Glucuronic Acid - chemistry</topic><topic>Hexuronic Acids - administration &amp; dosage</topic><topic>Hexuronic Acids - chemistry</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>In vitro deposition</topic><topic>Inhalatory administration</topic><topic>Ionic interaction</topic><topic>Lactose - chemistry</topic><topic>Lung - drug effects</topic><topic>Microscopy, Electron, Scanning</topic><topic>Microspheres</topic><topic>Particle Size</topic><topic>Powders</topic><topic>Pressure</topic><topic>Spray-drying</topic><topic>Viscosity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ceschan, Nazareth Eliana</creatorcontrib><creatorcontrib>Bucalá, Verónica</creatorcontrib><creatorcontrib>Ramírez-Rigo, María Verónica</creatorcontrib><creatorcontrib>Smyth, Hugh David Charles</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ceschan, Nazareth Eliana</au><au>Bucalá, Verónica</au><au>Ramírez-Rigo, María Verónica</au><au>Smyth, Hugh David Charles</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying</atitle><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle><addtitle>Eur J Pharm Biopharm</addtitle><date>2016-12</date><risdate>2016</risdate><volume>109</volume><spage>72</spage><epage>80</epage><pages>72-80</pages><issn>0939-6411</issn><eissn>1873-3441</eissn><abstract>[Display omitted] The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to focus on dry powder inhaler delivery systems. Atenolol is an antihypertensive drug with low oral bioavailability and gastrointestinal side effects. Because atenolol possesses adequate permeation across human epithelial membranes, it has been proposed as a good candidate for inhalatory administration. In a previous work, atenolol was combined with alginic acid (AA) and microparticles were developed using spray-drying (SD) technology. Different AA/atenolol ratios, total feed solid content and operative variables were previously explored. In order to improve particle quality for inhalatory administration and the SD yield, in this work the AA acid groups not neutralized by atenolol were kept either free or neutralized to pH∼7 and two different SD cyclones were used. Particle morphology, flow properties, moisture uptake and in vitro aerosolization behavior at different pressure drops were studied. When the AA acid groups were neutralized, particle size decreased as a consequence of the lower feed viscosity. The SD yield and in vitro particle deposition significantly increased when a high performance cyclone was employed, and even when lactose carrier particles were not used. Although the in vitro particle deposition decreased when the storage relative humidity increased, the developed SD powders showed adequate characteristics to be administered by inhalatory route up to storage relative humidities of about 60%.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27697595</pmid><doi>10.1016/j.ejpb.2016.09.020</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0939-6411
ispartof European journal of pharmaceutics and biopharmaceutics, 2016-12, Vol.109, p.72-80
issn 0939-6411
1873-3441
language eng
recordid cdi_proquest_miscellaneous_1835355149
source MEDLINE; Elsevier ScienceDirect Journals
subjects Administration, Inhalation
Aerosols
Alginates - administration & dosage
Alginates - chemistry
Animals
Antihypertensive Agents - chemistry
Atenolol
Atenolol - administration & dosage
Atenolol - chemistry
Desiccation
Drug Delivery Systems
Dry Powder Inhalers
Freeze Drying
Glucuronic Acid - administration & dosage
Glucuronic Acid - chemistry
Hexuronic Acids - administration & dosage
Hexuronic Acids - chemistry
Humans
Hydrogen-Ion Concentration
In vitro deposition
Inhalatory administration
Ionic interaction
Lactose - chemistry
Lung - drug effects
Microscopy, Electron, Scanning
Microspheres
Particle Size
Powders
Pressure
Spray-drying
Viscosity
title Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T13%3A32%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20feed%20counterion%20addition%20and%20cyclone%20type%20on%20aerodynamic%20behavior%20of%20alginic-atenolol%20microparticles%20produced%20by%20spray%20drying&rft.jtitle=European%20journal%20of%20pharmaceutics%20and%20biopharmaceutics&rft.au=Ceschan,%20Nazareth%20Eliana&rft.date=2016-12&rft.volume=109&rft.spage=72&rft.epage=80&rft.pages=72-80&rft.issn=0939-6411&rft.eissn=1873-3441&rft_id=info:doi/10.1016/j.ejpb.2016.09.020&rft_dat=%3Cproquest_cross%3E1835355149%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835355149&rft_id=info:pmid/27697595&rft_els_id=S0939641116306233&rfr_iscdi=true